BAXANO SURGICAL, INC.

CIK:0001230355|SEC Filings
v2.4.0.8
Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Revenue $ 4,656 $ 3,877 $ 9,068 $ 6,977
Cost of revenue 1,417 1,295 2,680 2,327
Gross profit 3,239 2,582 6,388 4,650
Operating expenses:        
Research and development 2,465 1,509 4,452 2,794
Sales and marketing 6,001 6,032 13,275 10,959
General and administrative 2,567 1,860 5,115 3,411
Merger and integration expenses 0 1,583 19 2,895
Total operating expenses 11,033 11,053 22,861 20,219
Operating loss (7,794) (8,471) (16,473) (15,569)
Non-operating items:        
Interest expense (759) (73) (1,135) (73)
Change in fair value of derivative and warrant liabilities 2,676 0 2,624 0
Other income, net 10 13 8 11
Net loss (5,867) (8,531) (14,976) (15,631)
Other comprehensive income (loss):        
Foreign currency translation adjustments (1) 1 (2) 0
Comprehensive loss (5,868) (8,530) (14,978) (15,631)
Net loss per common share - basic and diluted (in dollars Per Share) $ (0.12) $ (0.26) $ (0.31) $ (0.51)
Weighted average common shares outstanding - basic and diluted (in shares) 48,520 33,408 47,793 30,379
US Treasury and Government [Member]
       
Operating expenses:        
Charges related to U.S. Government settlement $ 0 $ 69 $ 0 $ 160